Phase 3 Study for Advanced Pancreatic Cancer Meets Survival Goal
Patients with locally advanced pancreatic cancer demonstrated a two-month difference in survival with tumor-treating fields versus chemotherapy.
High-dose vitamin C: Promising treatment extends survival of pancreatic cancer patients
StudyFinds' Dr. Faith Coleman speaks with the doctor testing a new vitamin C treatment that may double the survival time of cancer patients.
NovoCure's Tumor-Treating Electric Fields Shows Promise In Pancreatic Cancer Patients
On Monday, NovoCure Ltd (NASDAQ:NVCR) and Zai Lab Limited (NASDAQ:ZLAB) revealed topline data from the Phase 3 PANOVA-3 trial of Tumor-Treating Fields (TTFields) therapy concomitantly with gemcitabine and nab-paclitaxel as a first-line treatment for unresectable,
Novocure's tumor treating electric fields clear phase 3 pancreatic cancer trial
Novocure has cleared a phase 3 clinical study in pancreatic cancer, showing its tumor-treating electric fields could help against the notoriously recalcitrant disease. | The company’s wearable therapy improved overall survival as part of a first-line regimen for patients with inoperable pancreatic adenocarcinoma,
Novocure reports positive trial results for TTFields therapy in pancreatic cancer
Novocure this week announced positive topline results from its Phase 3 trial of its Tumor Treating Fields for pancreatic cancer.
Novocure's pancreatic cancer treatment meets main goal in late-stage study
Novocure said on Monday its experimental therapy extended the lives of patients with a form of advanced pancreatic cancer when combined with chemotherapy, achieving the primary goal in a late-stage trial.
Novocure Launches 49% After Pancreatic Cancer Treatment Succeeds
Novocure stock catapulted early Monday after the company's cancer-treating device succeeded in a study of patients with pancreatic cancer.
Novocure therapy succeeds in pancreatic cancer trial
Novocure (NVCR) achieves milestone in pancreatic cancer treatment with positive trial results for TTFields therapy, leading to a 25% surge in stock price.
Novocure Moves Pancreatic Cancer Treatment Forward With A 'First' Using TTFields
Novocure’s positive phase 3 results boost pancreatic cancer treatment prospects. Read why NVCR stock is worth watching with ...
pancan1d
Tumor Treating Fields Phase III Clinical Trial Results: What You Need to Know
In a Phase III clinical trial, a therapy known as Tumor Treating Fields (TTFields) increased survival for patients whose ...
Stocktwits on MSN1d
Novocure Stock Soars On Positive Pancreatic Cancer Trial Results, Retail Sentiment Surges
Shares of Novocure Ltd. skyrocketed over 55% on Monday afternoon, reaching levels last seen in August 2023, as the company ...
Targeted Oncology2h
DSMB Approves Continued GOBLET Cohort 5 Enrollment in Pancreatic Cancer
Enrollment in cohort 5 of the phase 1/2 GOBLET study will resume after the Data Safety Monitoring Board’s safety review.
Outsourcing-pharma1d
Novocure reports positive phase 3 results for tumor treating fields therapy
Novocure's PANOVA-3 trial shows TTFields therapy with chemotherapy improves survival in pancreatic cancer, marking a ...
emjreviews.com13d
High-Dose Vitamin C Improves Survival in Pancreatic Cancer
High-dose intravenous vitamin C doubles survival in metastatic pancreatic cancer, extending life without added toxicity or ...